Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
Introduction: The lungNENomics project analysed 300 lung neuroendocrine tumors (NETs), of which 259 cases were pathologically reviewed by six expert pathologists.
Conference:
Presenting Author: Mathian E
Authors: Mathian E, Drouet Y, Sexton-Oates A, Papotti M, Pelosi G,
Keywords: Lung neuroendocrine neoplasm, Pathology, Deep-learning, Ki-67, PHH3,
Introduction: Lung neuroendocrine tumors (LNETs) are subdivided into low-grade (typical) and intermediate-grade (atypical) carcinoids, at higher risk of developing metastases. We have previously identified 3 LNETs molecular groups with different prognoses, as well as “supra-carcinoids” with molecular profiles of higher-grade neuroendocrine carcinomas. Despite promising results, there is still no consensus on their differential diagnosis and treatment and little is known about how some tumors evolve toward more aggressive phenotypes.
Conference:
Presenting Author:
Authors: Foll M, Sexton-Oates A, Mathian E, Alcala N, Mangiante L,
Keywords: lung carcinoid, deep learning, genomic, evolution, multi-omics, spatial analyses,
#3401 Characterising aggressive pulmonary carcinoids through integrative omics analysis
Introduction: Atypical carcinoids, and our recently identified supra-carcinoids (Alcala et al. 2019) belong to the pulmonary carcinoid (PCA) group of low grade lung neuroendocrine tumors. Little is known about the underlying biology of these tumors, nor why some patients are prone to metastatic disease and tumor recurrence. To date, molecular analysis of these tumors has been limited, particularly with regard to whole-genome sequencing (WGS).
Conference:
Presenting Author:
Authors: Sexton-Oates A, Di Genova A, Alcala N, Mangiante L, Voegele C,
Keywords: pulmonary carcinoid, genome, transcriptome, epigenome, characterisation,
Introduction: Neuroendocrine tumors are rare understudied diseases at the molecular level, especially those occurring in sites outside the lung and the gastrointestinal track. This lack of knowledge has strong implications for the clinical management of these diseases (Rindi et al. Mad Pathol 2018).
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Fernandez-Cuesta L
Authors: Fernandez-Cuesta L, Foll M, Walter T, Girard N, Lantuejoul S,
Keywords: Rare Cancers genomics, lungNENomics, panNENomics, supra-carcinoids, tumor maps,
Our website automatically sets cookies, which are technically necessary for the operation of the website. By clicking "OK", Google Analytics and the associated cookies are also activated for the purpose of website analysis and optimization. Detailed Information and the possibility to revoke your consent at any time, you can find in our privacy policy.
These cookies are so-called "session cookies." They are automatically deleted after your visit.
Protects you from Cross-Site-Request-Forgery attacks.
Saves the current PHP session.
For webinar purposes, ENETS uses VIMEO as an embedded iframe on MY ENETS. VIMEO implements its own tracking system, which is beyond the of ENETS responsibility. By watching ENETS videos on the ENETS website, you also agree to the conditions of VIMEO: https://vimeo.com/privacy
This website uses Google Analytics, a web analytics service. It is operated by Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA. Google Analytics cookies are stored based on your consent Art. 6 (1) (a) DSGVO/GDPR, which we confirm via the consent banner.
For more information about how Google Analytics handles user data, see Google's privacy policy: https://support.google.com/analytics/answer/6004245?hl=en.